# Janssen Pharmaceuticals, Inc – FDA Inspection, Sep 27, 2024

Source: https://www.keypedia.com/records/fda_inspections/janssen-pharmaceuticals-inc/a957db33-ff2d-4e98-86e3-9332d9d2d54b
Source feed: FDA_Inspections

> FDA inspection 1229931 of Janssen Pharmaceuticals, Inc, September 27, 2024. Classification: No Action Indicated (NAI). 2 citations. Form 483 issued. 12 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1229931
- Company Name: Janssen Pharmaceuticals, Inc
- Inspection Date: 2024-09-27
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Bioresearch Monitoring: Human Drugs
- Product Type: Human Drugs
- Center: Human Drugs
- Office Name: New Jersey District Office
- Citation Count: 2

## Related Documents

- [FDA Inspection 1338168 - 2026-09-25](https://www.keypedia.com/records/fda_inspections/janssen-pharmaceuticals-inc/16fafd4a-7311-420b-b8bd-7c82af1e2eb7)
- FDA Inspection 1271223 - 2025-08-14
- [FDA Inspection 1131617 - 2020-09-28](https://www.keypedia.com/records/fda_inspections/janssen-pharmaceuticals-inc/3a8fe62f-7bb7-4a30-a70b-ff5a60a6a59a)
- FDA Inspection 1131381 - 2020-09-14
- FDA Inspection 1031605 - 2017-10-06

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/jay-b-shah/c437fff9-807e-4dea-80c0-8f77850db6f8)
- [Kellie B. Kelm](https://www.keypedia.com/people/kellie-b-kelm/df5eaff8-c13d-49e8-b2f6-c3d42a9a7daf)

Company: https://www.keypedia.com/companies/janssen-pharmaceuticals-inc/7d87f794-c8cc-4a2c-b985-4d62ebc2d60b

Office: https://www.keypedia.com/offices/new-jersey-district-office/6ff5e2e9-5cff-44c7-af24-5a55329a8248